Suppr超能文献

孕期使用拟交感神经类减充血剂:对胎儿的风险

Sympathomimetic decongestants during pregnancy: risks for the unborn child.

出版信息

Prescrire Int. 2016 Jun;25(172):153.

Abstract

In addition to the risk of cardiovascular events and neurological disorders, sympathomimetic decongestants have teratogenic potential, albeit weak, when taken during the first trimester of pregnancy, probably through disruption of the vascular system of the embryo and the pregnant woman. In the second and third trimesters of pregnancy, the fetus is exposed to the same adverse effects as the mother.

摘要

除了有心血管事件和神经紊乱的风险外,拟交感神经减充血剂在妊娠头三个月服用时具有致畸潜力,尽管这种潜力较弱,可能是通过破坏胚胎和孕妇的血管系统。在妊娠的第二和第三个月,胎儿会受到与母亲相同的不良影响。

相似文献

3
Over-the-counter sympathomimetics: a risk factor for cardiac arrhythmias in pregnancy.
South Med J. 1998 Dec;91(12):1153-5. doi: 10.1097/00007611-199812000-00011.
6
[Drug-induced rhinitis].[药物性鼻炎]
Cah Med. 1970 Oct 30;12(13):1087-9.
8
Nasal decongestants and paranoid psychosis.
Br J Psychiatry. 1970 Oct;117(539):439-40. doi: 10.1192/bjp.117.539.439.
9
Psychotic episodes associated with the use of common proprietary decongestants.
Am J Psychiatry. 1966 Oct;123(4):484-7. doi: 10.1176/ajp.123.4.484.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验